• Past and Upcoming Events

  • Prescriber Consultation Service

  • 2023 Membership Feedback Survey

  • Featured Resources

  • Research Paper of the Month

  • Research

  • Community Updates and Events

  • In the News

  • Ways to Get Involved



On September 13th, we hosted the research spotlight webinar: "Safer Supply Ottawa Research Evaluation Findings: Prescribed Stimulant Safer Supply". This webinar discussed the newest Safer Supply research evaluation findings from Ottawa programs with a focus on safer stimulants. Read and download the full report! A Q & A session with the speakers followed the presentation.

Our presenters:

  • Marlene Haines, RN, PhD Candidate, School of Nursing, University of Ottawa
  • Patrick O’Byrne, NP, PhD, Professor of Nursing, School of Nursing, University of Ottawa; Nurse Practitioner, Ottawa Sexual Health Clinic
  • Athena Tefoglou, RPN, B.Sc. in Nursing (Student), School of Nursing, University of Ottawa 
Click here for the webinar recording, as well as all the resources and links shared!

On September 21st, we hosted the official launch of the new evaluation report on the London InterCommunity Health Centre's (LIHC) Safer Opioid Supply Program! The goal of the evaluation was to examine and compare self-reported client outcomes from 2022 and 2023. In both years, clients identified reduced use of drugs from the unregulated market, reductions in overdose, and increased access to health services since starting safer supply. This report also examines which medications (both opioid and stimulant) that participants would like to be prescribed and their preferred mode of administration for SOS medications. A Q & A session with the speakers followed the presentation. Read and download the full report!

Our Speakers:

  • Dr. Gillian Kolla, PhD
  • Dr. Andrea Sereda, MD, Lead and Founding Physician for the Safer Opioid Supply (SOS) Program at LIHC
Click here for the webinar recording, as well as all the resources and links shared!


Members are welcome to join our weekly meeting drop-in meetings. It is an interdisciplinary group with prescribers, pharmacists, harm reduction workers, policy folks, nurses, people who use drugs, etc. Right now, we are meeting on Thursdays at 12pm ET. Zoom Link

**Please note: Our Thursday weekly drop-in meetings are cancelled on October 5th and October 26th. On October 12th, we will host our usual weekly drop-in meeting, and on October 19th, we will host a special Wound Care Workshop with Erin Telegdi and Patricia Coutts.**


Are you a health care provider who is involved in prescribing safer supply, e.g., NPs, MDs, PAs, RNs? If you are interested in attending our next clinician meeting on prescribing safer supply on Wednesday, October 4th at 12pm PT | 3pm ET, please register here. Clinician meeting goals include: (1) Connecting safer supply clinicians; (2) Discussing case studies; (3) Asking questions; and, (4) Sharing clinical experiences. Register now!

How are we doing?

We want to hear from you about what we are doing well, what hasn’t worked well, and what ideas you have for us!

This survey will take approximately 5–10 minutes to complete. Click here to fill it out! 

The survey is anonymous. We do not collect your name or email address. 

Thank you very much for participating!


Are you a doctor or nurse practitioner who works with people who use drugs?

  • Want to learn more about safer supply and how you can best support the people you work with?
  • Want access to an exclusive prescriber consultation service?

Help us scale up safer supply programs across Canada! Register for the consultation service, and you'll have email access to our physician consultant and our pharmacist consultant. You do not need to be an NSS-CoP member to access this service, but you do need to be a doctor or nurse practitioner.

Key Messages on Safer Supply: The NSS-CoP has assembled key messages on safer supply as well as a series of infographics and social media campaign packages. Updates to these key messages will happen on an ongoing basis as more research, evidence, and information emerges. Check it out now!

LIHC Safer Opioid Supply Program September 2023 Evaluation Report: A Comparison of SOS Client Outcomes from 2022 and 2023: This evaluation reports on client outcomes from the LIHC SOS program using self-reported survey data collected in spring of 2022 and again in spring of 2023 from clients of the SOS program. It is a follow-up to the first SOS program evaluation conducted in 2021. 

Characteristics of Substance-Related Toxicity Deaths in Ontario: Stimulant, opioid, benzodiazepine, and alcohol-related deaths – ODPRN: This joint report by the ODPRN and Public Health Ontario provides an overview on the trends and patterns of single and polysubstance (more than one substance) deaths from alcohol, benzodiazepines, opioids, and stimulants in Ontario (January 1, 2018 to December 31, 2021). 

Prescribed Safer Supply Protocols: Sufentanil – BCCSU and PHS: These resources provide a standardized protocol for the provision of sufentanil as a way to reduce reliance on the unregulated drug supply and associated harms. This protocol is adapted from PHS Community Services Society’s Sufentanil Policy. 

Prescribed Safer Supply Protocols: Fentanyl Tablet – BCCSU and PHS: These resources provide a standardized protocol for the provision of fentanyl tablets as a way to reduce reliance on the unregulated drug supply and associated harms. This protocol is adapted from PHS Community Services Society’s Fentanyl Tablet Policy. 

MySafe safer opioid supply program using biometric dispensing machines – CATIE Programming Connection: MySafe is a safer opioid supply program for individuals at high risk of overdose from consumption of illegal opioids. It uses secure biometric dispensing machines to provide daily doses of physician-prescribed opioids in the form of hydromorphone tablets. A qualitative study identified participant-reported facilitators, barriers and outcomes. Facilitators included non-witnessed use, ease of access and policies that allowed participants to plan and adapt their use. Barriers included technical issues and issues related to insufficient doses and potency. Outcomes included reduced illegal drug use, decreased overdose risk and improved health and well-being for participants. 

A Public Health Approach to Substance Use Handbook – Canadian Public Health Association: This handbook can be used alone as a self-guided workbook, or in a small group with or without facilitation. It can support self-reflection, community coordination, and the important cross-agency and system-wide conversations about how to widen and improve the response to substance use. It can also inspire respectful and destigmatizing conversations with people who use substances and engage with peer support networks. 

A Guide to Using Extended-Release Buprenorphine (Sublocade®) in Opioid Agonist Therapy (OAT) - ESCODI: The Équipe de soutien clinique et organisationnel en dépendance et itinérance (ESCODI) in Montréal recently published a guide to using extended-release buprenorphine (Sublocade®) in OAT. The NSS-CoP is pleased to be sharing the English translation of their new publication. Read and download it now!

NSS-CoP Resource Library: Did you know we have a resource library with OVER 1,500 resources on safer supply? You can access it for FREE anytime. It features academic journal articles, grey literature, knowledge translation materials, clinical practice guidelines, and more!
Schmidt, R. A., et al. (2023). ‘I don't chase drugs as much anymore, and I'm not dead’: Client reported outcomes associated with safer opioid supply programs in Ontario, Canada | Drug & Alcohol Review 

  • Results indicate multifaceted pathways to improved self-reported health and well-being among clients including changes in drug use practices, fewer overdoses, reduced criminalized activity, improved trust and engagement in health care, and increased social stability (e.g., housing).
  • Most clients reported that the intervention saved their life because of the reduced frequency of overdoses. Findings suggest that SOS programs improved clients' health outcomes and increase opportunities for engagement in health services.
  • Results provide insight into the mechanisms behind some of the emergent evidence on the impact of safer supply prescribing.
Chayama, K. L., et al. (2023). Housing-based syringe services programs to improve access to safer injecting equipment for people who inject drugs in Vancouver, Canada: a spatially oriented qualitative study | Harm Reduction Journal 
Ferguson, M., et al. (2023). Preferred stimulant safer supply and associations with methamphetamine preference among people who use stimulants in British Columbia: Findings from a 2021 cross-sectional survey | International Journal of Drug Policy 
Levenson, J., et al. (2023). Abolition and harm reduction in the struggle for “Care, Not Cages” | International Journal of Drug Policy 
Beck McGreevy, P., et al. (2023). Doing community-based research during dual public health emergencies (COVID and overdose) | Harm Reduction Journal 
MacDonald, M., et al. (2023). Trends in varying modes of drug use in opioid toxicity deaths in Ontario from 2017 to 2021 | International Journal of Drug Policy 
Cui, Z., et al. (2023). Characterizing Methamphetamine Use Among People Who Use Opioids: A Systematic Review | International Journal of Mental Health and Addiction 
Viste, D., et al. (2023). Association of drug overdoses and user characteristics of Canada’s national mobile/virtual overdose response hotline: the National Overdose Response Service (NORS) | BMC Public Health
Greer, A. M., et al. (2023). Police officer perceptions towards drug liberalization policies in the context of an overdose crisis in British Columbia, CanadaDrugs: Education, Prevention and Policy
Jiao, S., et al. (2023). How an emergency department is organized to provide opioid-specific harm reduction and facilitators and barriers to harm reduction implementation: a systems perspective | Harm Reduction Journal
Cano, M., et al. (2023). Overdose Deaths Involving Synthetic Opioids: Racial/Ethnic and Educational Disparities in the Eastern and Western US | Drug and Alcohol Dependence 
Zhu, D. T. (2023). Public health impact and harm reduction implications of xylazine-involved overdoses: a narrative review | Harm Reduction Journal 
Bertin, C., et al. (2023). People who inject oral morphine favor experimentation with injectable opioid substitution | Harm Reduction Journal 
Strum, R. P., et al. (2023). Quantifying the escalating impact of paramedic transported emergency department visits for opioid-related conditions in Ontario, Canada: A population-based cohort study | PLOS One 
Schneider, K. E., et al. (2023). High willingness to use overdose prevention sites among suburban people who use drugs who do not inject | Harm Reduction Journal 
Davidson, P. J. (2023). Impact of a high-volume overdose prevention site on social and drug disorder in surrounding areas in San Francisco | Drug and Alcohol Dependence 
Lorvick, J., et al. (2023). “Just another thing for me to stress off of”: Responses to unintentional fentanyl use in a community-based study of people who use opioids | Harm Reduction Journal 
Chen, Y., et al. (2023). Experiences of peer work in drug use service settings: A systematic review of qualitative evidence | International Journal of Drug Policy 
Chambers, L. C., et al. (2023). Buprenorphine Dose and Time to Discontinuation Among Patients With Opioid Use Disorder in the Era of Fentanyl | Substance Use and Addiction 
Various Authors. (2023). Narcofeminisms: Revisioning drug use (Volume 71, Issue 4) | Sociological Review 
We encourage NSS-CoP members to email with submissions to include in our newsletter. Content examples include but are not limited to community-led projects, webinars and events, peer-reviewed articles, grey literature, and more!
Harm Reduction, Drug Policy, and Media with Garth Mullins - Harm Reduction Nurses Association (HRNA): In this open webinar happening on October 11th at 12pm PT | 3pm ET, HRNA will host an Ask Me Anything (AMA) on media, harm reduction, and drug policy with Garth Mullins, a drug user activist and award-winning radio documentarian. He is host and executive producer of the Crackdown Podcast where drug users cover the drug war as war correspondents. This is Garth’s second overdose crisis. He used injection heroin for over a decade and is now on methadone. He is a member of the Vancouver Area Network of Drug Users and is also a trade union organizer and musician. Register now!
The Dr. Peter's Centre invites people who currently or formerly used drugs in front line harm reduction positions to attend an in-person dialogue session on Friday, October 6th from 12pm to 1:30pm (AT) at the Halifax North Memorial Public Library in the Terry Simon's Auditorium. We want to better understand what front line peers need to have their mental wellness supported.
Attendees will be provided with:
  • A $60 cash honorarium
  • Snacks
  • Coffee
People wanting to attend who are not located in the Halifax Regional Municipality are welcome to join us on zoom from 2:00 to 3:30pm AT. Any harm reduction workers that use(d) drugs that live in the Atlantic Region are invited to attend this virtual version of the dialogue session. The link to register is here. The $60 honorarium also applies to the virtual session option.
National and General News: British Columbia:
Ontario: Yukon, Northwest Territories, and Nunavut: Québec (et en français s'il vous plaît!):
Atlantic Region (Nova Scotia, New Brunswick, Prince Edward Island, Newfoundland and Labrador):

Share your skills:

We’d like to create opportunities for skills sharing. Let us know if you would like to offer a workshop or present to the membership.

Share your successes:

Share your success stories, your reports, and safer supply resources that you develop with the NSS-CoP membership through:

How can we help? Let us know what you need! Our goal is to support you by assisting in areas around your programs, organizations, and communities!

Want to provide us with anonymous feedback, suggestions, and/or comments? Fill out this anonymous feedback survey - it is completely anonymous and confidential.

Have a question that you’d like to ask? Email us: or send a message via Twitter, Instagram, Facebook, and LinkedIn.
(519) 660-0875 ext. 1264

Want to change how you receive these emails?
You can update your preferences or unsubscribe from this list.